66Health
Policy

Another Update to the Medical Insurance Drug List: More Good Drugs and Rare-Disease Medicines May Be Covered

Policy Research Group2026-07-17visibility8.9万 reads
Another Update to the Medical Insurance Drug List: More Good Drugs and Rare-Disease Medicines May Be Covered

Seeing a doctor is expensive, and drug costs are often the biggest part. The dynamic adjustment mechanism of the national medical insurance drug list is designed to bring more clinically valuable, reasonably priced drugs into coverage and ease the burden on patients. In recent years, negotiated access for rare-disease medicines and innovative drugs has drawn particular attention.

lightbulbKey takeaways

  • The insurance list adds and removes items through dynamic adjustment
  • Negotiated access trades volume for price, bringing expensive drugs into coverage at lower prices
  • More rare-disease medicines are covered, easing family burdens
  • Specific reimbursement ratios depend on enrollment type and local policy

Why the list needs dynamic adjustment

Medical technology keeps advancing and new drugs keep coming to market. Through periodic review and negotiated access, the insurance list can add and remove items, bringing in drugs with proven efficacy and reasonable value while removing those of low clinical value, so limited funds go where they matter most.

The negotiated-access mechanism trades volume for price, reaching agreement between companies and the insurer, so many once-expensive drugs enter coverage after steep price cuts. This is hugely significant for patients with chronic or serious illness who take medication long term.

Access to rare-disease medicines is improving

Although rare-disease patients are a small group, their medication burden is often extremely heavy. Bringing more rare-disease medicines into coverage reflects the insurer's attention to vulnerable groups and genuinely relieves the financial pressure on these families.

Getting a drug onto the list is only the first step; implementation, hospital stocking and outpatient reimbursement all follow, requiring coordination among many parties before the policy dividend truly reaches patients.

What it means for ordinary enrollees

After the list is adjusted, some drugs that previously had to be fully self-paid may become reimbursable, lowering actual costs. Follow the officially published list information, and when seeing a doctor proactively ask your physician and pharmacist about the reimbursement status of your drugs.

Reimbursement ratios, deductibles and caps also depend on your enrollment type and local policy. How much you can actually claim is determined by local medical insurance rules.

This article is for health education reference only and cannot replace professional medical diagnosis or treatment. If you feel unwell, please seek medical care promptly.